Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bowel Function After Minimally Invasive Hysterectomy
NCT04263896Phase 4Completed
- Sponsor
- University of Chicago
- Start
- Aug 2019
- Primary completion
- Jun 2024
- Modality
- Injectable Hydrogels, Implantable Hydrogels, Biodegradable Polymers
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of polyethylene glycol 3350 in constipation (2 arms), sponsored by University of Chicago. Primary endpoints: Patient Assessment of Constipation Symptoms Questionnaire and Patient Assessment of Constipation Quality of Life Questionnaire. Started Aug 2019; status: completed.
02
Drugs
polyethylene glycol 3350
03
Conditions
constipation
Beyond the preview
Go deeper on NCT04263896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04263896.